[Epilepsy after febrile seizures. Predisposing factors and role of phenobarbital in its prophylaxis (author's transl)].
Palencia Luances R, Díez Cordero Jm, F Tresierra, S Sánchez-Villares
Abstract
Palencia Luances R, Díez Cordero Jm, F Tresierra, S Sánchez-Villares
Abstract
Authors studied two different groups of patients. One of them with febrile seizures and the other febrile seizures associated to epilepsy, in order to find risk factors for the presentation of this one. They conclude that epilepsy has a presentation rate of 9,6% in patients with previous febrile seizures, having the highest risk when they show previous familial seizures, neonatal pathology and altered EEG after the first febrile convulsion. They study the role of phenobarbital taken after febrile seizures, as prophylaxis. No effect was observed in the prevention of following epilepsy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Authors studied two different groups of patients. One of them with febrile seizures and the other febrile seizures associated to epilepsy, in order to find risk factors for the presentation of this one. They conclude that epilepsy has a presentation rate of 9,6% in patients with previous febrile seizures, having the highest risk when they show previous familial seizures, neonatal pathology and altered EEG after the first febrile convulsion. They study the role of phenobarbital taken after febrile seizures, as prophylaxis. No effect was observed in the prevention of following epilepsy.
Key concepts: Phenobarbital, Medicine, Epilepsy, Febrile seizure, Convulsion, Febrile convulsions, Presentation (obstetrics), Pediatrics